Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
“These findings emphasize the importance of early recognition of IPV and timely intervention to prevent further harm to the victim,” authors of research published in Academic Radiology cautioned.
Providers screening women with dense breasts and benign breast disease should consider individualized mammogram protocols for these patients, authors of the study suggested.
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence.
Outside of the correlation between measurements obtained using both modalities, the researchers also identified Hounsfield unit thresholds that could reliably rule out osteoporosis.
"This awareness is important to avoid oversight of symptoms like dyspnea and vague chest discomfort, which can easily be interpreted as symptoms caused by the known disease COPD,” experts involved in the study said.
Of the 51 plans, just 31% were consistent with the USPSTF recommendations pertaining to the starting age and frequency of screening women who are at average risk of developing breast cancer.